Difference between revisions of "Scopolamine (Scopoderm)"
Jump to navigation
Jump to search
m (→Also known as) |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
*'''Brand names:''' Scopoderm, Transderm Scop | *'''Brand names:''' Scopoderm, Transderm Scop | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Topical medications]] | [[Category:Topical medications]] | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Muscarinic receptor antagonist]] | [[Category:Muscarinic receptor antagonist]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1979]] |
Latest revision as of 19:05, 30 July 2018
Mechanism of action
Scopolamine is a tropane alkaloid drug with muscarinic antagonist effects, including emesis prevention. Popular due to the fact that it is a patch so does not have to be given by the oral route, but can have many intolerable side effects. No known antineoplastic properties.
Also known as
- Brand names: Scopoderm, Transderm Scop